跳至主要内容
临床试验/NCT06104293
NCT06104293已完成不适用

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber

Alyatec1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2022年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Alyatec
入组人数
24
试验地点
1
主要终点
Optimal concentration of grass allergens (Phl p 5 in ng/m3) to induce a positive rhino-conjunctivitis response in subjects allergic to grass pollen during 3 hours of exposure to grass pollen allergens in the ALYATEC Environmental Exposure Chamber (EEC)

研究概览

简要总结

The aim of this study is to determine the optimal concentration of grass pollen allergens inducing rhinoconjunctivitis in subjects allergic to grass pollen in ALYATEC allergen exposure chamber.

Four concentrations of grass pollen allergen (Phl p 5) are tested during 3-hour exposures: 0, 30, 60 and 90 ng/m3.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

The grass pollen allergen (Phl p 5) concentrations corresponding to concentrations A, B, C and D are assigned randomly by the technician and the pharmacist of the exposure chamber so that neither the investigator, the participants nor the clinical and medical staff are aware of the exposure doses.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Main Inclusion Criteria:
  • Subjects with symptoms of allergic rhinoconjunctivitis to grass pollen without associated asthma, requiring anti-allergic treatment for at least 2 consecutive pollen seasons;
  • Subjects with positive skin prick tests to grass pollen extracts (Phleum pratense): papule diameter ≥ 5 mm compared to the negative control (NaCl reaction < 2 mm));
  • Subjects with Phl p 5 specific recombinant Immunoglobulin E ≥ 0.70 kIU/L;
  • Forced expiratory volume in 1 second (FEV1) ≥ 70% of predicted value at screening and before allergenic exposures;
  • Women of childbearing age must have a negative pregnancy test at screening and before exposure visits;

排除标准

  • Specific immunotherapy (SIT) to grass pollen allergens for more than one month in the 3 years preceding the screening visit;
  • Ongoing specific immunotherapy to another allergen
  • History of anaphylaxis following exposure to grass pollen or grass SITs;
  • Ear, Nose & Throat or ocular surgical intervention in the 6 months preceding inclusion;

结局指标

主要结局

Optimal concentration of grass allergens (Phl p 5 in ng/m3) to induce a positive rhino-conjunctivitis response in subjects allergic to grass pollen during 3 hours of exposure to grass pollen allergens in the ALYATEC Environmental Exposure Chamber (EEC)

时间窗: 0 to 3 hours

The optimal concentration of grass pollen allergens Phl p 5 in ng/m3 will be determined by evaluating the Area Under the Curve (AUC) of the rhino-conjunctivitis TSS (Total Symptoms Score). The value of the TSS varies from 0 (no symptom) to 24 (highest symptoms)

次要结局

  • Time to obtain a rhino-conjunctivitis response during the 3 hours of exposure to grass pollen allergens in the ALYATEC EEC(0 to 3 hours)
  • Frequency of bronchial response during 3 hours of exposure in the ALYATEC EEC(0 to 3 hours)
  • Optimal concentration of grass allergens (Phl p 5 in ng/m3) to induce a positive rhinitis response in subjects allergic to grass pollen during 3 hours of exposure to grass allergens in the ALYATEC Environmental Exposure Chamber (EEC)(0 to 3 hours)
  • Use of concomitant medications during and after exposures in the EEC ALYATEC(0 to 24 hours)

研究者

发起方
Alyatec
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Determination of Grass Pollen Allergen Concentration... | 临床试验